138 related articles for article (PubMed ID: 32918615)
1. Resveratrol binds and activates RKIP protein in colorectal cancer.
Dariya B; Behera SK; Srivani G; Aliya S; Alam A; Nagaraju GP
Amino Acids; 2020 Sep; 52(9):1299-1306. PubMed ID: 32918615
[TBL] [Abstract][Full Text] [Related]
2. Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer.
Wang Y; Wang LY; Feng F; Zhao Y; Huang MY; Shao Q; Chen C; Sheng H; Chen DL; Zeng ZL; Xu RH; Li YH
Oncol Rep; 2015 Oct; 34(4):2106-14. PubMed ID: 26238523
[TBL] [Abstract][Full Text] [Related]
3. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
4. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
[TBL] [Abstract][Full Text] [Related]
5. A new model for raf kinase inhibitory protein induced chemotherapeutic resistance.
Al-Mulla F; Bitar MS; Feng J; Park S; Yeung KC
PLoS One; 2012; 7(1):e29532. PubMed ID: 22279539
[TBL] [Abstract][Full Text] [Related]
6. Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
Koelzer VH; Karamitopoulou E; Dawson H; Kondi-Pafiti A; Zlobec I; Lugli A
Br J Cancer; 2013 May; 108(10):2088-96. PubMed ID: 23632477
[TBL] [Abstract][Full Text] [Related]
7. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
9. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability.
Al-Mulla F; Hagan S; Al-Ali W; Jacob SP; Behbehani AI; Bitar MS; Dallol A; Kolch W
J Clin Pathol; 2008 Apr; 61(4):524-9. PubMed ID: 18375747
[TBL] [Abstract][Full Text] [Related]
10. Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.
Nie F; Cao J; Tong J; Zhu M; Gao Y; Ran Z
J Biomed Sci; 2015 Jul; 22(1):56. PubMed ID: 26177829
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α and RKIP: a computational approach for pancreatic cancer therapy.
Srivani G; Behera SK; Dariya B; Chalikonda G; Alam A; Nagaraju GP
Mol Cell Biochem; 2020 Sep; 472(1-2):95-103. PubMed ID: 32562168
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
Shemon AN; Heil GL; Granovsky AE; Clark MM; McElheny D; Chimon A; Rosner MR; Koide S
PLoS One; 2010 May; 5(5):e10479. PubMed ID: 20463977
[TBL] [Abstract][Full Text] [Related]
13. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
Granovsky AE; Rosner MR
Cell Res; 2008 Apr; 18(4):452-7. PubMed ID: 18379591
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
[TBL] [Abstract][Full Text] [Related]
16. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
[TBL] [Abstract][Full Text] [Related]
17. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
18. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.
Trakul N; Menard RE; Schade GR; Qian Z; Rosner MR
J Biol Chem; 2005 Jul; 280(26):24931-40. PubMed ID: 15886202
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for RKIP binding with its substrate Raf1 kinase.
Wu Z; Fu C; Shi L; Ruan L; Lin D; Guo C
Biotechnol Lett; 2014 Sep; 36(9):1869-74. PubMed ID: 24863296
[TBL] [Abstract][Full Text] [Related]
20. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
